Image

Outcomes of Treatment Using the ERMI Shoulder Flexionater ®

Outcomes of Treatment Using the ERMI Shoulder Flexionater ®

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Study 1 - Adhesive Capsulitis Study - 90 patients The purpose of this study is to compare treatment of patients with symptoms of adhesive capsulitis, primary and secondary, between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Study 2 - Postoperative Shoulder Stiffness Study - 90 patients The purpose of this study is to compare treatment of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Study 3 - Stiffness after MUA Study - enroll all eligible patients (goal of at least 15) The purpose of this study is to compare treatment of patients who have undergone manipulation under anesthesia or lysis of adhesions between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Description

Study 1 - Adhesive Capsulitis Study (AC)

Objective: The purpose of this study is to compare treatment efficacy of patients with symptoms of primary and secondary adhesive capsulitis between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.

  1. Prospective randomized control trial
  2. Sample size - 90 patients
  3. Study Groups:
  4. Group I - Physical Therapy Only
  5. Group II - Flexionater® only
  6. Group III - Flexionater® and Physical Therapy
  7. Length of study - 2-year follow-up from last enrolled patient

Study 2 - Postoperative Shoulder Stiffness Study (POS)

Objective: The purpose of this study is to compare treatment efficacy of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Patients treated with Physical Therapy alone; II) Patients treated with the ERMI Shoulder Flexionater® alone; III) Patients treated with PT + Device in the treatment.

  1. Prospective randomized control trial
  2. Sample size - 90 enrolled patients
  3. Study Groups:
  4. Group I - Physical Therapy only
  5. Group II - Flexionater® only
  6. Group III - Flexionater® and Physical Therapy
  7. Length of study - 2-year follow-up from last enrolled patient

Study 3 - Secondary Surgery Study (SAM)

Objective: The purpose of this study is to compare recovery of patients who have undergone a manipulation under anesthesia or a lysis of adhesions between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.

  1. Prospective randomized control trial
  2. Sample size - 90 enrolled patients
  3. Study Groups:
  4. Group I Physical Therapy Only
  5. Group II - - Flexionater® only
  6. Group III - Flexionater® and Physical Therapy
  7. Length of study - 2-year follow-up from last enrolled patient

Eligibility

For Study Group 1- Adhesive Capsulitis (AC)

Inclusion Criteria:

  • Exhibits symptoms of adhesive capsulitis i. Shoulder pain with limited motion for more than one month ii. AND ≤ 30 degrees external rotation with arm at side iii. AND ≤ 130 degrees forward flexion d. Cortisone shot for all patients

Exclusion Criteria:

  • a. No prior shoulder surgery b. Infection c. Rheumatoid arthritis d. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder

For Study Group 2 - Postoperative Shoulder Stiffness Study (POS)

Inclusion Criteria:

        c. Is not recovering normally based on objective criteria set for screening process i. Step
        1 - Follow patients -all post-op patients with indicated procedures (see # 7 for list.) ii.
        Step 2 - Screen Patients -does patient meets inclusion criteria at 6 weeks or 3 months of
        follow-up?
          1. < 15 degrees external rotation with arm at side at 6 weeks post-op
          2. OR < 90 degrees forward flexion at 3 months post-op iii. Step 3 - Enroll patients that
             meet inclusion criteria and assign group
        Exclusion Criteria:
        a. Revision surgery b. Infection c. Rheumatoid arthritis
        7. Procedures included
          1. Shoulder arthroscopic procedures (29827, 29828, 29823,29824, 29826)
          2. ORIF Humerus fracture (23615)
             For Study Group 3, Secondary Surgery Study (SAM)
             Inclusion Criteria:
          3. Underwent a manipulation under anesthesia or a lysis of adhesions procedure
        Exclusion Criteria:
        a. Infection b. Rheumatoid arthritis c. Any structural or systemic disorder that could
        result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis
        evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound
        imaging iii. history of major trauma or surgery involving the shoulder
        7. Procedures included
          1. Manipulation under anesthesia (23700)
          2. Lysis of adhesions (29825)

Study details
    Adhesive Capsulitis of Shoulder

NCT05384093

Foundation for Orthopaedic Research and Education

18 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.